Clinical Study
The Florida Melanoma Trial I: A Prospective Multicenter Phase I/II Trial of Postoperative Hypofractionated Adjuvant Radiotherapy with Concurrent Interferon-Alfa-2b in the Treatment of Advanced Stage III Melanoma with Long-Term Toxicity Follow-Up
Table 7
Estimated overall survival and failure-free survival probabilities at time points of interest along with corresponding 95% CIs ().
|